Advancing excellence in laboratory medicine for better healthcare worldwide

Task Force on Pharmacogenetics (Integrated Project) - (TF-PG)

Membership

Name Position Country Term Time in Office
M. Linder Chair US 1st 2017 03 - 2019 12
T. Framroze Ashavaid Member  IN 1st 2017 05 - 2019 12
O. Slanař Member  CZ 1st 2017 05 - 2019 12
W. Steimer Member DE 1st 2017 05 - 2019 12
M. Relling Consultant US    
R. van Shaik Past Chair NL    

Aim

The aim of the Task Force is to facilitate integration of pharmacogenetic testing into routine diagnostics at the appropriate quality standards.

Objectives

  1. Obtain information on the potential clinical utility of specific pharmacogenetic tests
  2. Obtain information on current perception of genetic variants to be tested
  3. Obtain information on clinical recommendations based on the pharmacogenetic test results from the clinical disciplines involved.
  4. Discuss and weigh the information obtained.
  5. Prepare guiding documents, with participation of the clinical disciplines involved, per drug/gene combination for pharmacogenetic testing, addressing who to test, how to test, how to interpret and how to report.
  6. Identify Pharmacogenetics Expert Labs, in collaboration with the Committee for Molecular Diagnostics.

Delivery

  1. Network of pharmacogenetic experts from in- and outside Clinical Chemistry.
  2. Network of specific contact persons within the relevant clinical disciplines.
  3. Guidance documents: TPMT testing and 6-mercaptopurine/azathioprine, CYP2C19 testing and clopidogrel, CYP2D6 testing and tamoxifen.
  4. Presentation of ongoing work of IFCC TF-PG in presentations and posters at different conferences.

Accountability

The Task Force is directly responsible to tde EB through the President.

List of Corresponding Members, nominated by National Societies

Name Full and Affiliate Member Societies
Kayode Adedapo Association of Clinical Chemists Nigeria (ACCN)
Suleyman Aydin

Turkish Biochemical Society (TBS)

List of Corresponding Members, nominated by Corporate Members

Name Corporate Member
Bruce Jordan ROCHE

List of Addresses

Chair

Prof. Mark W. LINDER
Department of Pathology and Laboratory Medicine
University of Louisville, School of Medicine
Louisville, Kentucky 40202
USA
E-mail: mark.linder@louisville.edu

Members

Dr. Tester Framroze ASHAVAID
Department of Laboratory Medicine
Biochemistry Section
S-1, Lalitha Girdhar Annexe Building
P.D.Hinduja National Hospital &
Medical Research Centre,
Veer Savarkar Marg, Mahim,
Mumbai – 400 016.
Tel. : 91-22-24447936 (O)
E-mail: dr_tashavaid@hindujahospital.com

Dr. Ondřej SLANAŘ
Dept of Pharmacology
1st Faculty od Medicine
Charles University
Prague and General Teching Hospital
Prague - CZ
E-mail: ondrej.slanar@lf1.cuni.cz

Prof. Werner STEIMER
Institute for Clinical Chemistry and Pathobiochemistry
Munich University of Technology
Klinikum rechts der Isar, Ismaningenstr.22
D-81675 Munich -DE
E-mail: werner.steimer@tum.de

Past Chair

Dr. Ron VAN SCHAIK
Department of Clinical Chemistry
Erasmus University Medical Centre
Gavendijkwal 230
3015 CE Rotterdam
The Netherlands
Tel: +31 10 70 33119
E-mail: r.vanschaik@erasmusmc.nl

Consultant

Dr Mary RELLING
Pharmaceutical Sciences
MS 313, Room I5112
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
E-Mail: mary.relling@stjude.org

 
Website developed by Insoft Digital